ACTIVE

Temmune Therapeutics

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-2,2 M €-99,6 %over 1 year
Gross margin-377 k €-17,0 %over 1 year
Equity2 M €-9,5 %over 1 year

Identity

Source · BCE/KBO

Temmune Therapeutics is a Public limited company incorporated in 2021. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Mechelen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0776.938.722
Incorporation
08/11/2021
Legal form
Public limited company
Registered office
Kardinaal Mercierplein 2
2800 Mechelen · FlandreSee on map
Contributed capital
4 347 047,79 €
Latest accounts
31/12/2025
Signals
Solid equityGood liquidity

Financials

Source · NBB, 5 filings

Trend over 4 financial years

2025202420232022
Income statement
Gross margin-377 k €-322,1 k €-560,7 k €-737,4 k €
EBITDA-377,7 k €-323,2 k €-561,1 k €-737,9 k €
Operating result-2,3 M €-1,2 M €-561,1 k €-737,9 k €
Net result-2,2 M €-1,1 M €-564,6 k €-744,7 k €
Balance sheet
Equity2 M €2,2 M €103 k €230,3 k €
Total assets3,4 M €2,6 M €197,9 k €276,6 k €
Cash1,5 M €538,1 k €134,4 k €276,1 k €
Debts1,4 M €423,6 k €94,8 k €46,4 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 3 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Participatiemaatschappij Vlaanderen0455.777.660Represented by Wilms Tobias
Director18/12/2025 → 18/12/2031
Tomas Heyman
Director07/04/2025 → 18/12/2031
LIFE of SCI0563.547.828Represented by De Maeyer Joris
Persoon belast met dagelijks bestuursince 01/04/2025
Dirk Reyn
Director23/09/2024 → 14/03/2030
Keith McCullagh
Director23/09/2024 → 14/03/2030
Roderick Verhelst
Director23/09/2024 → 14/03/2030

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Thomas Heyman
Directorlisted until the 2023 accounts
Keith McCullugh
Directorlisted until the 2023 accounts
Groovy.Bio0776.937.633Represented by Dirk Reyn
Manager19/10/2021 → 2022 accounts

Other companies at this address

Kardinaal Mercierplein 2 2800 Mechelen
CompanyCBE no.
Administratiekantoor Temmune Therapeutics● Active
1025.942.868
ALL IN ONE DELIVERY● Bankrupt
0691.693.043
Amber Therapeutics Belgium● Active
1042.186.806
Anima● Active
0696.648.852
ANIRES● Active
1016.204.761
AVENO CARGO CENTER● Active
0648.895.257
Bausch + Ströbel Customer Care Center Belgium● Active
0802.924.725
BENELUX & PARTNERS● Active
0764.941.208
BlueStone Underwriting● Active
1042.777.516
C&A ELECTRICITY● Bankrupt
0797.043.258
CaptureAge● Active
0734.747.383
CHARMEWONING● Bankrupt
0826.369.328
Cybercontract● Active
0557.948.651
Delgabre Group● Bankrupt
0739.758.919
ESKENS BENELUX● Active
0439.773.650
Foundation CaptureAge● Active
1015.127.269
FRUTAROM BELGIUM● Active
0403.593.145
HANOVER DISPLAYS● Active
0737.945.118
HERA● Active
0441.391.273
ICON Clinical Research Belgium● Active
0467.032.927

Full financial information

Source · NBB
2025202420232022
Type of accountAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202308/11/2021
Closing of the financial year31/12/202531/12/202431/12/202331/12/2022
Length of the financial year12 months12 months12 months14 months
Filing date07/04/202618/07/202518/07/202528/06/2023
General meeting13/03/202616/07/202516/07/202523/06/2023
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 5 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202513/03/202607/04/2026DutchPDF
Abridged model31/12/202416/07/202518/07/2025DutchPDF
Abridged modelCorrection31/12/202316/07/202518/07/2025DutchPDF
Abridged model31/12/202308/03/202426/03/2024DutchPDF
Abridged model31/12/202223/06/202328/06/2023DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

6 active · 3 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Participatiemaatschappij Vlaanderen0455.777.660Represented by Wilms Tobias
Director18/12/2025 → 18/12/2031
Tomas Heyman
Director07/04/2025 → 18/12/2031
LIFE of SCI0563.547.828Represented by De Maeyer Joris
Persoon belast met dagelijks bestuursince 01/04/2025
Dirk Reyn
Director23/09/2024 → 14/03/2030
Keith McCullagh
Director23/09/2024 → 14/03/2030
Roderick Verhelst
Director23/09/2024 → 14/03/2030

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Thomas Heyman
Directorlisted until the 2023 accounts
Keith McCullugh
Directorlisted until the 2023 accounts
Groovy.Bio0776.937.633Represented by Dirk Reyn
Manager19/10/2021 → 2022 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates20/03/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/01/2026
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates30/06/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office30/01/2025
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN
    PDF
  • Mandates30/09/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office05/03/2024
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other10/11/2021
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings4 filings
Mandates
Participatiemaatschappij Vlaanderen
Tomas Heyman
LIFE of SCI
Dirk Reyn
Roderick Verhelst
Keith McCullagh
Thomas Heyman
Keith McCullugh
Groovy.Bio
20212022202320242025202620272028202920302031
Temmune Therapeutics
Kardinaal Mercierplein 2, 2800 Mechelen
Director
Director
Persoon belast met dagelijks bestuur
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Kardinaal Mercierplein 2, 2800 MechelenCurrent
accounts 2023 → 2025
Accounts 2025 · 2026-00077831
Roekendreef 14, 2350 Vosselaar
accounts 2023
Accounts 2023 · 2024-00052073
Goswin De Stassartstraat 19, 2800 Mechelen
accounts 2022
Accounts 2022 · 2023-00195077

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Temmune TherapeuticsCurrent
accounts 2022 → 2025
Accounts 2025 · 2026-00077831

Events

  1. 2025
    Annual accounts 2025-2,2 M €↓
  2. 2024
    Annual accounts 2024-1,1 M €↓
  3. 2023
    Annual accounts 2023-564,6 k €↑
  4. 2022
    Annual accounts 2022-744,7 k €
  5. 08/11/2021
    IncorporationPublic limited company